Alector (ALEC) Total Liabilities (2018 - 2026)
Alector (ALEC) posted quarterly Total Liabilities of $229.5 million for Q1 2026, down 26.83% year-over-year from $313.7 million in Q1 2025, and down 12.59% quarter-over-quarter from $262.6 million in Q4 2025.
Alector (ALEC) Total Liabilities (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Total Liabilities for 9 consecutive years, with $229.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 26.83% year-over-year to $229.5 million; the TTM figure through Mar 2026 stood at $229.5 million (down 26.83% YoY), while the FY2025 annual figure was $262.6 million, down 23.11% from the prior year.
- Total Liabilities fell to $229.5 million in Q1 2026 per ALEC's latest filing, from $262.6 million in the prior quarter.
- Across five years, Total Liabilities topped out at $686.9 million in Q1 2022 and bottomed at $229.5 million in Q1 2026.
- Historically, Total Liabilities has averaged $441.4 million across 5 years, with a median of $456.6 million in 2024.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 223.2% — and 2025, when it sank 32.11%.
- Alector's Total Liabilities stood at $573.2 million in 2022, then declined by 14.92% to $487.7 million in 2023, then retreated by 29.97% to $341.5 million in 2024, then slipped by 23.11% to $262.6 million in 2025, then declined by 12.59% to $229.5 million in 2026.
- Business Quant data shows ALEC's Total Liabilities at $229.5 million in Q1 2026, $262.6 million in Q4 2025, and $277.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 212.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 212.83 Mn |
| Mar 31, 2026 | 229.53 Mn |
| Dec 31, 2025 | 262.59 Mn |
| Sep 30, 2025 | 277.57 Mn |
| Jun 30, 2025 | 285.25 Mn |
| Mar 31, 2025 | 313.69 Mn |
| Dec 31, 2024 | 341.50 Mn |
| Sep 30, 2024 | 397.09 Mn |
| Jun 30, 2024 | 420.16 Mn |
| Mar 31, 2024 | 456.59 Mn |
| Dec 31, 2023 | 487.67 Mn |
| Sep 30, 2023 | 509.84 Mn |
| Jun 30, 2023 | 512.43 Mn |
| Mar 31, 2023 | 565.33 Mn |
| Dec 31, 2022 | 573.21 Mn |
| Sep 30, 2022 | 583.93 Mn |
| Jun 30, 2022 | 601.16 Mn |
| Mar 31, 2022 | 686.92 Mn |
| Dec 31, 2021 | 513.93 Mn |
| Sep 30, 2021 | 518.34 Mn |